PPARA and metabolic dysfunction-associated steatotic liver disease: Lentinan can improve NAFLD by activating the peroxisome proliferator-activated receptor alpha (PPAR-α) pathway to improve hepatic steatosis and reduce oxidative stress and apoptosis [90].